These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17908623)

  • 1. The International Harmonization Project for response criteria in lymphoma clinical trials.
    Cheson BD
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):841-54. PubMed ID: 17908623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
    Cheson BD
    Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging and evaluation of the patient with lymphoma.
    Cheson BD
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):825-37, vii-viii. PubMed ID: 18954739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revised response criteria for malignant lymphoma.
    Cheson BD; Pfistner B; Juweid ME; Gascoyne RD; Specht L; Horning SJ; Coiffier B; Fisher RI; Hagenbeek A; Zucca E; Rosen ST; Stroobants S; Lister TA; Hoppe RT; Dreyling M; Tobinai K; Vose JM; Connors JM; Federico M; Diehl V;
    J Clin Oncol; 2007 Feb; 25(5):579-86. PubMed ID: 17242396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of response criteria for clinical trials of sarcoma treatment.
    Schuetze SM; Baker LH; Benjamin RS; Canetta R
    Oncologist; 2008; 13 Suppl 2():32-40. PubMed ID: 18434637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.
    Abrey LE; Batchelor TT; Ferreri AJ; Gospodarowicz M; Pulczynski EJ; Zucca E; Smith JR; Korfel A; Soussain C; DeAngelis LM; Neuwelt EA; O'Neill BP; Thiel E; Shenkier T; Graus F; van den Bent M; Seymour JF; Poortmans P; Armitage JO; Cavalli F;
    J Clin Oncol; 2005 Aug; 23(22):5034-43. PubMed ID: 15955902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using consensus methods to develop clinical practice guidelines for intensive care: the intensive care collaborative project.
    Rolls KD; Elliott D
    Aust Crit Care; 2008 Nov; 21(4):200-15. PubMed ID: 18922699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we need an early unfavorable (intermediate) stage of Hodgkin's lymphoma?
    Specht L; Raemaekers J
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):881-96. PubMed ID: 17908626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for clinical studies with compression devices in patients with venous disorders of the lower limb.
    Rabe E; Partsch H; Jünger M; Abel M; Achhammer I; Becker F; Cornu-Thenard A; Flour M; Hutchinson J; Issberner K; Moffatt Ch; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Apr; 35(4):494-500. PubMed ID: 18249571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
    Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ;
    J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern treatment of Hodgkin lymphoma.
    Bartlett NL
    Curr Opin Hematol; 2008 Jul; 15(4):408-14. PubMed ID: 18536581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular lymphocyte predominant Hodgkin lymphoma with non-invasive or early invasive growth pattern suggests an early step of the disease with a highly favorable outcome.
    Carbone A; Spina M; Gloghini A; Ponzoni M; Doglioni C; Tirelli U
    Am J Hematol; 2013 Feb; 88(2):161-2. PubMed ID: 23349009
    [No Abstract]   [Full Text] [Related]  

  • 14. Spondyloarthritis update: new insights regarding classifcation, pathophysiology, and management.
    Mease PJ
    Bull NYU Hosp Jt Dis; 2008; 66(3):203-9. PubMed ID: 18937633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methods for formulating recommendations for clinical practice].
    Dosquet P; Matillon Y
    J Radiol; 1995 Nov; 76(11):1004-6. PubMed ID: 8594173
    [No Abstract]   [Full Text] [Related]  

  • 16. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia.
    Creutzig U; Kaspers GJ
    J Clin Oncol; 2004 Aug; 22(16):3432-3. PubMed ID: 15310791
    [No Abstract]   [Full Text] [Related]  

  • 17. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
    Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
    Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies.
    Oddis CV; Rider LG; Reed AM; Ruperto N; Brunner HI; Koneru B; Feldman BM; Giannini EH; Miller FW;
    Arthritis Rheum; 2005 Sep; 52(9):2607-15. PubMed ID: 16142757
    [No Abstract]   [Full Text] [Related]  

  • 19. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
    Valent P; Akin C; Escribano L; Födinger M; Hartmann K; Brockow K; Castells M; Sperr WR; Kluin-Nelemans HC; Hamdy NA; Lortholary O; Robyn J; van Doormaal J; Sotlar K; Hauswirth AW; Arock M; Hermine O; Hellmann A; Triggiani M; Niedoszytko M; Schwartz LB; Orfao A; Horny HP; Metcalfe DD
    Eur J Clin Invest; 2007 Jun; 37(6):435-53. PubMed ID: 17537151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
    Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN
    J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.